Acadia Pharmaceuticals | Zinsaufwendungen Für Schuld



Interest Expense On Debt Veränderung Datum
Acadia Pharmaceuticals 0 4.12M 2024-09
ALKERMES USD 4.65M 1.35M 2024-12
Alnylam Pharmaceuticals USD 38.97M 4.6M 2024-12
Biogen USD 60M 200K 2024-12
BioMarin Pharmaceutical USD 2.58M 391K 2024-12
Bristol-Myers Squibb USD 496M 9M 2024-12
Corcept Therapeutics 6M 6M 2024-06
Cytokinetics USD 22.59M 296K 2024-12
Eisai 777M 167M 2024-12
Eli Lilly USD 224.7M 78.4M 2024-12
Incyte USD 419K 355K 2024-12
J&J USD 137M 56M 2024-12
Moderna USD 6M 0 2024-12
Neurocrine Biosciences USD 1.1M 0 2024-03
Pfizer USD 739M 45M 2024-12
Prothena 0 0 2024-06
PTC Therapeutics USD 43.35M 1.24M 2024-12
Sarepta Therapeutics USD 4.92M 86K 2024-09
Ultragenyx Pharmaceutical 15.52M 190K 2024-12
Vertex Pharmaceuticals USD 2.8M 4.7M 2024-12



Acadia Pharmaceuticals Zinsaufwendungen Für Schuld - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.